Apolipoprotein A5 Gene Promoter Region<b><i>-1131T/C</i></b> Polymorphism Is Associated with Risk of Ischemic Stroke and Elevated Triglyceride Levels: A Meta-Analysis
Authors: Pi Yan , Zhang Lili , Yang Qingwu , Li Binghu , Guo Lu , Fang Chuanqin , Gao Changyue , Wang Jingzhou , Xiang Jing , Li Jingcheng 
Published: June 2012

<b><i>Background:</i></b> The association between polymorphism <i>-1131T/C</i> in the promoter region of apolipoprotein A5 (APOA5) and ischemic stroke and plasma triglyceride (TG) levels remains controversial. To better clarify the association between APOA5-<i>1131T/C</i> and risk of ischemic stroke and plasma TG levels, we performed a meta-analysis to examine the allele and genotype of APOA5-<i>1131T/C</i> polymorphism in ischemic stroke cases and controls. <b><i>Methods:</i></b> Based on the search of PubMed, Embase, MEDLINE, CNKI (National Knowledge Infrastructure) and CBM (Chinese BioMedical Literature Database) databases, we identified and abstracted outcome data from all articles to evaluate the association between APOA5 and ischemic stroke/plasma TG levels. The pooled odds ratios (ORs) with 95% confidence intervals (CIs) were performed in dominant model (CC + TC vs. TT), recessive model (CC vs. TC + TT), homozygote comparison (CC vs. TT) and heterozygote comparison (TC vs. TT). The association between dominant model (CC + TC vs. TT) and plasma TG/total cholesterol/high-density lipoprotein cholesterol levels was measured by a weighted mean difference (WMD) with its corresponding 95% CI. To evaluate the ethnicity-specific effects, subgroup analyses were performed by ethnic group. <b><i>Results:</i></b> A meta-analysis containing 2,294 ischemic stroke cases and 1,858 controls from 8 case-control studies was performed. The results showed that APOA5-<i>1131T/C</i> polymorphism was significantly associated with ischemic stroke in all comparison models (CC + TC vs. TT, OR = 1.70, 95% CI = 1.24–2.32; CC vs. TC + TT, OR = 1.36, 95% CI = 0.98–1.90; CC vs. TT, OR = 1.73, 95% CI = 1.34–2.23; TC vs. TT, OR = 1.67, 95% CI = 1.19–2.36). On subgroup analysis by ethnicity, similarly significant associations were found in both Asians and Europeans, and the Europeans possessed a higher risk of ischemic stroke, especially in CC versus TT model (OR = 4.47, 95% CI = 1.33–15.06). Significant association between the C allele and elevated TG levels was detected in both ischemic stroke cases and controls; the TG levels were higher in the ischemic stroke cases and controls carrying the APOA5-<i>1131</i>C allele than in the noncarriers (CC + TC vs. TT, cases WMD = 0.43, 95% CI = 0.27–0.59; controls WMD = 0.51, 95% CI = 0.35–0.66). Similar within-group comparison of the total cholesterol and high-density lipoprotein cholesterol levels did not show any difference. <b><i>Conclusions:</i></b> Our meta-analysis revealed that the APOA5-<i>1131T/C</i> polymorphism is associated with a significant risk of ischemic stroke and elevated TG levels. The CC genotype and C allele might be a genetic risk factor that increases susceptibility of ischemic stroke and elevates plasma TG levels, and might be a useful target for clinical therapeutic intervention.